Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.63M | -51.09M | -47.05M | -54.88M | -60.27M |
| Total Depreciation and Amortization | 4.05M | 4.20M | 4.07M | 4.11M | 4.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.29M | 27.82M | 32.59M | 36.59M | 43.18M |
| Change in Net Operating Assets | 29.38M | 45.13M | 32.66M | 25.41M | 760.00K |
| Cash from Operations | 31.08M | 26.06M | 22.28M | 11.24M | -12.19M |
| Capital Expenditure | -5.04M | -5.17M | -2.41M | -1.79M | -2.85M |
| Sale of Property, Plant, and Equipment | 44.00K | 44.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -340.00M | -350.00M | -350.00M | -350.00M | -- |
| Cash from Investing | -345.00M | -355.13M | -352.41M | -351.79M | -2.85M |
| Total Debt Issued | 0.00 | 402.50M | 402.50M | 402.50M | 402.50M |
| Total Debt Repaid | -52.06M | -52.06M | -- | -- | -- |
| Issuance of Common Stock | 3.60M | 6.80M | 12.50M | 22.68M | 33.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.12M | -13.36M | -13.36M | -13.36M | -12.24M |
| Cash from Financing | -49.58M | 343.88M | 401.65M | 411.82M | 424.22M |
| Foreign Exchange rate Adjustments | 7.52M | -1.71M | 22.11M | 1.72M | 5.27M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -355.98M | 13.11M | 93.63M | 72.99M | 414.44M |